1. Greenwald P. Cancer chemoprevention.
BMJ. 2002 Mar 23;324(7339):714-8.
2. Messina MJ. Legumes and soybeans:
overview of their nutritional profiles and health effects. Am J Clin
Nutr. 1999 Sep;70(3 Suppl):439S-50S.
3. Yamamoto S, Sobue T, Sasaki S, et al. Validity and reproducibility
of a self- administered food-frequency questionnaire to assess isoflavone
intake in a Japanese population in comparison with dietary records
and blood and urine isoflavones. J Nutr. 2001 Oct;131(10):2741-7.
4. Barnes S. Effect of genistein on in vitro and in vivo models
of cancer. J Nutr. 1995 Mar;125(3 Suppl):777S-83S.
5. Jordan VC, Morrow M. Tamoxifen, raloxifene, and the prevention
of breast cancer. Endocr Rev. 1999 Jun; 20(3):253-78.
6. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene
on risk of breast cancer in postmenopausal women: results from the
MORE randomized trial. JAMA. 1999 Jun 16;281:2189-97.
7. Lee HP, Gourley L, Duffy SW, Esteve J, Day NE. Dietary effects
on breast cancer risk in Singapore. Lancet. 1991 May 18;337(8751):1197-00.
8. Hirose K, Tajima K, Hamajima N. A large-scale, hospital-based
case control study of risk factors of breast cancers according to
menopausal status. Japan J Cancer Res. 1995 Feb;86(2):146-54.
9. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones,
and breast cancer risk in Japan. J Natl Cancer Inst. 2003 Jun 18;95(12):906-13.
10. Setchell KD. Soy isoflavones—benefits and risks from nature’s
selective estrogen receptor modulators (SERMs). J Am Coll Nutr. 2001
Oct;20(5):354S-62S.
11. Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM. Phytoestrogen
intake and endometrial cancer risk. J Natl Cancer Inst. 2003 Aug 6;95(15):1158-64.
12. Spitz M, Strom Y, Yamura Y, et al. Epidemiologic determinants
of clinically relevant prostate cancer. Int J Cancer. 2000 May 20;89(3):259-64.
13. Sonoda T, Nagata Y, Mori M, et al. A case-control study of diet
and prostate cancer in Japan: possible protective effect of tradition-
al Japanese diet. Cancer Sci. 2004 Mar;95(3):238-42.
14. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK.
Soybean phyto- chemicals inhibit the growth of trans-plantable human
prostate carcinoma and tumor angiogenesis in mice. J Nutr. 1999 Sep;129(9):1628-35.
15. Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal
C, Agarwal R. In vivo suppression of hormone-refractory prostate cancer
growth by inositol hexaphosphate: induction of insulin-like growth
factor binding protein-3 and inhibition of vascular endothelial growth
factor. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):244-50.
16. Hikosaka A, Asamoto M, Hokaiwado N, et al. Inhibitory effects
of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-
1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 2004
Mar;25(3):381- 7. Epub 2003 Dec 04.
17. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake
reduce prostate cancer incidence? The Adventist Health Study (United
States). Cancer Causes Controls. 1998 Dec;9(6):553-7.
18. Ozasa K, Nakao M, Watanabe Y, et al. Serum phytoestrogens and
prostate cancer risk in a nested case-control study among Japanese
men. Cancer Sci. 2004 Jan;95(1):65-71.
19. Wei H, Saladi R, Lu Y, et al. Isoflavone genistein: photoprotection
and clinical implications in dermatology. J Nutr. 2003 Nov;133(11
Suppl):3811S-19S.
20. Anthony MS, Charkson TB, Williams JK. Effects of soy isoflavones
on atherosclerosis: potential mechanisms. Am J Clin Nutr. 1998 Dec;68(6
Suppl):1390S-3S.
21. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones
improve plasma lipids in normocholesterolemic, pre-menopausal women.
Am J Clin Nutr. 2000 Jun;71(6):1462-9.
22. Wangen KE, Duncan AM, Xu X, Carr TP, Kurzer MS. Soy isoflavones
improve plasma lipids in normocholesterolemic and mildly hypercholesterolemmic
postmenopausal women. Am J Clin Nutr. 2001 Feb;73(2):225- 31.
23. Jenkins DJA, Kendall CWC, Jackson CC, et al. Effects of high-
and low-isoflavone soy foods on blood lipids, oxidized LDL, homo-
cysteine, and blood pressure in hyperlipi- demic men and women. Am
J Clin Nutr. 2002 Aug;76(2):365-72.
24. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens
in obesity and diabetes. Am J Clin Nutr. 2002 Dec;76(6):1191-201.
25. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa
RJ. Equol is a novel anti-androgen that inhibits prostate growth and
hormone feedback. Biol Reprod. 2004 Apr;70(4):1188-95.
|